FDA | What's New
Follow
Financial Transparency and Efficiency of the Prescription Drug User Fee Act, Biosimilar User Fee Act, and Generic Drug User Fee Amendments - 09/30/2025
On September 30, 2025 FDA will hold its annual public meeting and opportunity for public comment on Financial Transparency and Efficiency of PDUFA, BsUFA, and GDUFA.
